Parvaiz, Rizwan https://orcid.org/0000-0002-9328-9020
Vindbjerg, Erik
Crespi, Bernard
Happe, Francesca
Schalbroeck, Rik
Al-Sayegh, Zainab
Danielsen, Ida-Marie
Tonge, Bruce
Videbech, Poul
Abu-Akel, Ahmad
Funding for this research was provided by:
Sofiefonden (IWOV-Legal.FID4107425)
Trygfonden (153588)
Takeda Pharmaceuticals International
Article History
Received: 12 August 2022
Accepted: 14 March 2023
First Online: 28 March 2023
Declarations
:
: The study is approved by the Ethical Committee of the Capital Region of Denmark (approval number H-21039423), and the project is reported to the Danish Data Protection Agency. The study will be conducted in accordance with the Helsinki Declaration 1964, including subsequent revisions. Participants will only be included after signing an informed consent based on oral and written information. The participants may, at any time, choose to withdraw from the study without being required to explain and without affecting the person's future treatment. The study investigators are under the impression that the questionnaires and investigations will not lead to any discomfort for the subjects. There are no known expected short- or long-term risks associated with the present study.
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Signed ICMJE forms have been obtained and can be provided upon request.